Clinical Trial Details
EORTC-30894
Back to Clinical Trials Database
Phase III study of primary chemotherapy (CMV) in T2G3, T3 and T4a, NO-X, M0 transitional cell carcinoma of the bladder (MRC/EORTC Collaborative Study)
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 30-Nov-1989 Date Step1 close: 30-Jun-1995 |
Data management at EORTC | Yes |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 400 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |